Boston Scientific's EBIT per Share for the
three
months ended in Mar. 2026 was MXN15.10.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN50.19.
During the past 12 months, the average EBIT per Share Growth Rate of Boston Scientific was 26.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 23.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 33.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 10.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Boston Scientific's EBIT per Share or its related term are showing as below:
MEX:BSX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -39.4 Med: 11.05 Max: 60.8
Current: 23.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Boston Scientific was 60.80% per year. The lowest was -39.40% per year. And the median was 11.05% per year.
MEX:BSX's 3-Year EBIT Growth Rate is ranked better than 68.7% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs MEX:BSX: 23.40
Boston Scientific (MEX:BSX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Boston Scientific EBIT per Share Related Terms
Boston Scientific EBIT per Share Historical Data
* Premium members only.
The historical data trend for Boston Scientific's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN50.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (MEX:BSX) has a EBIT per Share of MXN50.19 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Boston Scientific and its competitors. According to the industry distribution chart, Boston Scientific ranks #215 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 31.3%.
Is Boston Scientific's EBIT per Share too high?
Boston Scientific's current EBIT per Share is MXN50.19. Based on the distribution chart, Boston Scientific ranks #215 out of 687 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's EBIT per Share compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #215 out of 687 companies for EBIT per Share. This puts Boston Scientific in the upper half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Boston Scientific and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Boston Scientific's current EBIT per Share is MXN50.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,851.53, compared to a current price of MXN778.00 — trading 58% below its estimated fair value. The current EBIT per Share is MXN50.19. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current EBIT per Share is MXN50.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (MEX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of MXN778.00 is trading 58% below its estimated GF Value™ of MXN1,851.53.
GuruFocus considers Boston Scientific to be Significantly Undervalued.
Key valuation signals for MEX:BSX:
EBIT per Share: MXN50.19
GF Value™: MXN1,851.53 vs. price of MXN778.00 (58% below fair value)
No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score
Get the complete analysis for MEX:BSX
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BSX has been successfully added to your 
